HealthEquity (NASDAQ:HQY) Given New $128.00 Price Target at Deutsche Bank Aktiengesellschaft

HealthEquity (NASDAQ:HQY) had its price objective increased by stock analysts at Deutsche Bank Aktiengesellschaft from $120.00 to $128.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential upside of 57.12% from the company’s current price.

A number of other brokerages also recently weighed in on HQY. Royal Bank Of Canada dropped their target price on HealthEquity from $110.00 to $100.00 and set an “outperform” rating on the stock in a report on Wednesday. Barrington Research cut their target price on shares of HealthEquity from $125.00 to $110.00 and set an “outperform” rating for the company in a research note on Wednesday. BTIG Research decreased their target price on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a research report on Tuesday, February 17th. KeyCorp raised their price objective on shares of HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a report on Thursday, January 8th. Finally, Barclays dropped their target price on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, February 18th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $110.36.

HealthEquity Price Performance

Shares of HQY traded up $1.90 during mid-day trading on Thursday, hitting $81.47. The company’s stock had a trading volume of 382,371 shares, compared to its average volume of 1,034,357. The stock has a market capitalization of $6.96 billion, a price-to-earnings ratio of 33.17, a PEG ratio of 0.99 and a beta of 0.26. HealthEquity has a fifty-two week low of $72.76 and a fifty-two week high of $116.65. The firm has a 50-day moving average price of $80.93 and a 200 day moving average price of $90.20. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.05. The business had revenue of $334.59 million during the quarter, compared to analyst estimates of $332.48 million. HealthEquity had a return on equity of 13.82% and a net margin of 16.39%.HealthEquity’s quarterly revenue was up 7.3% on a year-over-year basis. On average, research analysts predict that HealthEquity will post 2.32 EPS for the current fiscal year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the sale, the executive vice president directly owned 73,979 shares in the company, valued at $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.50% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Institutional investors and hedge funds have recently made changes to their positions in the company. William Blair Investment Management LLC bought a new position in shares of HealthEquity in the 4th quarter valued at about $169,956,000. Norges Bank bought a new position in HealthEquity in the fourth quarter valued at approximately $66,927,000. Westfield Capital Management Co. LP boosted its stake in HealthEquity by 124.6% in the second quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after acquiring an additional 701,819 shares during the last quarter. AQR Capital Management LLC grew its holdings in HealthEquity by 148.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after acquiring an additional 661,795 shares during the period. Finally, Millennium Management LLC raised its position in shares of HealthEquity by 151.5% during the 4th quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock valued at $87,173,000 after acquiring an additional 573,283 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Key HealthEquity News

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Q4 beat and raised outlook — HealthEquity reported record revenue and earnings, new HSAs-from-sales growth, and raised its fiscal 2027 outlook, driven by HSA inflows and improving margins; these results and the guidance raise near-term revenue and profit visibility. HealthEquity Reports Record Revenue, Earnings and New HSAs…
• Positive Sentiment: Profitability and cash economics improved — Management highlighted margin expansion (net income up sharply year-over-year) and better cash economics that underpin higher free cash flow expectations; Seeking Alpha upgraded based on these improvements. HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade)
• Neutral Sentiment: Investor materials published — Earnings call transcripts and highlights are available for deeper read-through of guidance detail, HSA trends and segment commentary (useful for modeling but not new news). HealthEquity Q4 2026 earnings call transcript
• Negative Sentiment: Analyst price-target trims — Several firms cut price targets (Barrington, RBC, JPMorgan lowered targets from prior levels), which could cap upside or temper momentum despite continued bullish ratings; note the firms largely kept outperform/overweight recommendations. Benzinga price target coverage Tickerreport: JPMorgan price-target note

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.